Search results
FDA Expands Orphan Drug Designation for SurVaxM, I | Newswise
Newswise· 4 days agoBUFFALO, N.Y. — The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy ...
15 Life-Altering Moments In The Lives Of Cancer Survivors That Will Give You A New Perspective On...
BuzzFeed via Yahoo News· 5 days agoPositive by nature and diligent with testing from age 50, after two biopsies, the word 'cancer' set...
A new 'one-two punch' method for improving checkpoint inhibitor therapy for cancers, including...
Medical Xpress· 4 days agoA Scripps Research team has now found that ruxolitinib, an approved immunosuppressive drug,...
Treatment of Blood Cancers
Digital Journal· 6 days ago(NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs...
Cedarville University professor continuing cancer treatment research with students’ help
Dayton Daily News· 3 days agoA local professor, who orginally hails from Abuja, Nigeria, is continuing his research on the...
Birmingham University team finds new drug development approach
Pharmaceutical Technology via Yahoo Finance· 5 days agoThough the engineering of new enzymes is a distant goal, the latest findings pave the way for...
Innovent Reports Oncology Pipeline Updates at Investor Meeting
Yucaipa News Mirror· 6 days agoAt several major international oncology annual meetings this year, Innovent presented clinical data on multiple cancer drug candidates, including 10 oral ...
Can Weight Loss Drugs Like Wegovy and Zepbound Help You Live a Longer Life?
Healthline via AOL· 6 days agoIn the year 2024 there does not remain any pharmaceutical drug, vitamin, mineral or technique that...
Lincoln clinic among first in region to offer new Alzheimer's treatment
KLKN Lincoln· 5 days agoA Lincoln clinic is among the first in the region to offer a new treatment for Alzheimer’s disease....
COVID Pandemic May Have Disrupted Cervical Cancer Screenings
Medscape· 18 hours agoNew research found women aged 21-65 years who were due for a Papanicolaou (Pap) test to screen for...